This month is a momentous occasion, celebrating the nearly 15 years of the formalization of medical device regulations in Korea. Which is also a moment to reflect – how has the industry evolved since then, and what are the major themes to tackle ahead?APACMed, the voice of the medical device industr
The Ministry of Food and Drug Safety (MFDS) is taking aggressive action against Kolon Pharmaceutical’s recent illegal distribution of flu medicine Comiflu (oseltamivir phosphate) to a daycare via a donation group without a doctor’s prescription.The ministry is probing Kolon and the entire pharmaceut
Novo Nordisk Korea has recently launched two new type 2 diabetes drugs – Rybelsus and Ozempic – raising expectations among local doctors that the drug will become a game-changer for Korean patients."One of the most important aspects of treating type 2 diabetes is to reduce cardiovascular complicatio
AngioLab announced the results of the phase 2 McEye study of ALS-L1023, an investigational drug to treat wet age-related macular degeneration (AMD).The company explored the optimal dose of ALS-L1023 combined with ranibizumab (brand name: Lucentis) and evaluated the safety and efficacy in 126 patient
CellBion said Wednesday it has signed a development, manufacturing, and supply agreement with the Centre for Probe Development and Commercialization (CPDC), a Canadian radiopharmaceuticals company, for Lu-177-radiolabelled prostate-specific membrane antigen (PSMA-DGUL) therapeutic agent.Under the ac
The surge of the Omicron virus was behind Korea’s record-high monthly death figure in March, Statistics Korea said Wednesday.The number of deaths in March was 44,487, an increase of 67.6 percent (17,937) from a year earlier, the highest figure since the government started compiling monthly deaths in
After CAR-T cell therapy Kymriah (tisagenlecleucel) became reimbursable in April, Korean doctors are shifting the treatment focus to CAR-T cell therapy to treat relapsed/refractory diffuse large B-cell lymphoma (DLBCL).However, only a limited number of Korean hospitals can prescribe Kymriah despite
Researchers at Seoul National University Bundang Hospital (SNUBH) have developed a technology that can diagnose sleep apnea using only the microphone of a smartphone device.Sleep apnea is a sleep disorder symptom where patients temporarily stop breathing or experience their airways narrowing during
Medipost said it would establish a subsidiary specializing in CDMO (contract development and manufacturing organization) business in cell and gene therapy.In a public filing on Tuesday, Medipost said it would change the investment method for CDMO in North America. Earlier, Medipost had said that it
Genexine, a Korean biotech firm, said it would deliver a corporate presentation at the upcoming H.C. Wainwright Global Investment Conference in the U.S.H.C. Wainwright, a U.S. investment bank, invites promising companies and holds a conference for investors twice a year.The investment conference wil
Hanmi Pharmaceutical said the company would start marketing its blockbuster hypertension drug Amosartan under the brand name Meiyaping in China in September. It marked the first homegrown blood pressure combination therapy to enter the Chinese market.The launch follows Beijing Hanmi Pharmaceutical,
GC Pharma said it obtained marketing approval for Rozetelpine, a four-drug combination treatment for hypertension/hyperlipidemia.Rozetelpine combines hypertension medicines telmisartan and amlodipine with hyperlipidemia drugs rosuvastatin and ezetimibe.GC Pharma confirmed Rozetelpine’s efficacy in a
Reflecting the continuous decline of new Covid-19 cases, health authorities on Tuesday set the pandemic’s risk at a “low level” nationwide, the second-lowest of their five-tier rating system.It was the first time the entire nation entered the low-risk level since the government introduced the weekly
Monkeypox is spreading to the Middle East following Europe and the U.S., but the health authorities said they had established a test and diagnosis system to prepare for a possible outbreak in Korea."We completed developing and evaluating monkeypox’s diagnostic tests and reagents back in 2016," the K
Bixink Therapeutics is accelerating efforts to build a diverse digital therapeutics (DTx) portfolio by clinching a series of DTx deals. Bixink is a biotech subsidiary of KPS Corp.On Tuesday, Bixink said it signed an agreement with LimbixHealth, a U.S. company, for the exclusive local development and
Chong Kun Dang said it would exclusively market Baxter Korea’s Caelyx, a recurrent ovarian cancer treatment, in Korea. Under the contract, Chong Kun Dang will distribute, sell, and market Caelyx to Korean hospitals and clinics from July.“We will strategically conduct distribution, sales, and marketi
Almost eight out of 10 Koreans support the legalization of euthanasia or doctor-assisted suicide, a survey showed on Tuesday.The survey, conducted by Professor Yoon Young-ho of the Department of Family Medicine at Seoul National University Hospital (SNUH), asked the opinions of 1,000 Koreans 19 and
Genome Insight CEO Ju Young-seok received the Human Genome Organization’s (HUGO) Chen Award of Excellence.HUGO awards the Chen Award of Excellence annually to two young scientists who have extraordinary work or suggested a new treatment in human genomics.Ju, a professor at the Korea Advanced Institu
Fewer hospital visits during the Covid-19 pandemic pushed up the incidence of diabetic ketoacidosis (DKA) among pediatric diabetes patients, a study said.DKA is an acute metabolic complication that occurs when blood sugar rises due to insulin deficiency in diabetic patients. Symptoms of DKA vary fro
Genencell said that it has signed an exclusive distributorship agreement with Ordi Pharma FZ-LLC, a UAE-based pharmaceutical company, for the exclusive distribution rights of ES16001, an oral Covid-19 treatment, in Middle East countries and Turkey.Ordi Pharma is a subsidiary of DEM Pharmaceuticals,